Chromium-insulin reduces insulin clearance and enhances insulin signaling by suppressing hepatic insulin-degrading enzyme and proteasome protein expression in KKAy mice

JDS-CRI-003 (CRI) is a novel form of insulin that has been directly conjugated with chromium (Cr) instead of zinc. Our hypothesis was that CRI enhances insulin’s effects by altering insulin degrading enzyme (IDE) and proteasome enzymes. To test this hypothesis, we measured hepatic IDE content and p...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zhong Q Wang, Yongmei eYu, Xian H Zhang, James eKomorowski
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2014-07-01
Col·lecció:	Frontiers in Endocrinology
Matèries:	Liver insulin signaling Proteasome Chromium-insulin IRS-1 Insulin degrading enzyme
Accés en línia:	http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00099/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!